quasi architebeat vitae dicta sunt explicabo nemo enim ipsam voluptatem quia voluptassit.
Excepteur sint occaecat cupidatat non proident sunt culpa qui officia deserunt mollit anim id est laborum. sed spiciatis unde omnis natus error Inventore.
quasi architebeat vitae dicta sunt explicabo nemo enim ipsam voluptatem quia voluptassit.
Excepteur sint ocecat pro dent sunt in culpa qui.
Excepteur sint ocecat pro dent sunt in culpa qui.
Excepteur sint ocecat pro sunt in culpa. qui officia deserunt mollit anim id est. perspiciatis unde.
Excepteur sint ocecat pro sunt in culpa. qui officia deserunt mollit anim id est. perspiciatis unde.
Excepteur sint ocecat pro sunt in culpa. qui officia deserunt mollit anim id est. perspiciatis unde.
Lorem ipsum dolor amet consectet adipiscing sed do eiusmod tempor incidunt labore dolor magna aliqua ipsum suspen disse.
Lorem ipsum dolor amet consectet adipiscing sed do eiusmod tempor incidunt labore dolor magna aliqua ipsum suspen disse.
Lorem ipsum dolor amet consectet adipiscing sed do eiusmod tempor incidunt labore dolor magna aliqua ipsum suspen disse.
Our group expertise in mass spectrometry-based analysis of clinical samples. The primary focus of the lab is understanding the molecular underpinnings of common ocular diseases, identifications of biomarkers of disease for improved diagnostics and prognostics and monitoring of treatment response.
The research laboratory is interested in exploring the signal cascades that determine the course and severity of the ocular disorders for applications in early clinical diagnosis and identification of novel therapeutic targets by using high throughput techniques such as transcriptome analysis and proteomic analysis.
Pubmed link for publications:
https://pubmed.ncbi.nlm.nih.gov/?term=Vrushali+Deshpande